Review
Copyright ©2014 Baishideng Publishing Group Inc.
World J Immunol. Nov 27, 2014; 4(3): 130-140
Published online Nov 27, 2014. doi: 10.5411/wji.v4.i3.130
Table 1 Head-to-head study characteristics with subcutaneous and sublingual
Ref.YearAllergenStudy designNo. of patientsFindings
Quirino et al[84]1996Grass pollenDouble-blind, double-dummySCIT (n = 10) SLIT (n = 10) No placebo groupSignificant reduction in symptoms and medications for SCIT and SLIT groups ↑ Total specific IgG, ↑specific IgG4 and ↓skin reactivity for SCIT only
Mungan et al[83]1999Dust miteSingle-blind, placebo controlledSCIT (n = 10) SLIT (n = 15) Placebo (n = 11)↓ Rhinitis symptoms with SLIT ↓ Skin reactivity with SCIT ↑ Specific IgG4 with SCIT
Khinchi et al[82]2004Birch pollenRandomized, double-blind, double-dummy, placebo-controlledSCIT (n = 21) SLIT (n = 18) Placebo (n = 19)Significant reduction in symptoms and medications for SCIT vs placebo and SLIT vs placebo No difference between SCIT and SLIT groups
Mauro et al[86]2007Birch pollenRandomized, double-blind, double-dummySCIT (n = 19) SLIT (n = 15)No difference in mean symptom and medication score between SCIT and SLIT Specific IgG4 with SCIT
Tahamiler et al[88]2008Dust miteOpen label, randomizedSCIT (n = 96) SLIT (n = 97)↓ Rhinitis and conjunctivitis symptoms scores and nasal provocation score with SCIT and SLIT (greater improvement with SCIT)
Eifan et al[85]2010Dust miteOpen label, randomized, controlledSCIT (n = 16) SLIT (n = 16) Pharmacotherapy (n = 16)↓ Rhinitis and asthma symptom score, total medication score ↓ Skin reactivitiy with SCIT and SLIT ↓ Specific IgE with SCIT and SLIT
Keles et al[87]2011Dust miteOpen label, randomized, controlledSCIT (n = 11) SLIT (n = 13) SCIT plus SLIT (n = 14) Pharmacotherapy (n = 12)Reduction in total symptom score and total medication score in all immunotherapy groups ↓ Skin reactivity with SCIT ↑ Specific IgG4 for SCIT and SCIT plus SLIT
Yukselen et al[89]2012Dust miteRandomized, double-blind, double-dummy, placebo-controlledSCIT (n = 10) SLIT (n = 11) Placebo (n = 10 )Significant reduction in rhinitis and astma symptom score with SCIT Skin reactivity with SCIT and SLIT ↑ Specific IgG4 with SCIT